Theravance Biopharma (TBPH) Current Deferred Revenue (2013 - 2023)
Theravance Biopharma (TBPH) posted Current Deferred Revenue of $24,000 for Q3 2023, unchanged from $24,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Current Deferred Revenue (2013 - 2023) Analysis & Trends
Since Q4 2013, Theravance Biopharma has reported Current Deferred Revenue for 40 quarters.
- Annual Current Deferred Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -28.1% (FY2017 to FY2022).
- In prior years, Theravance Biopharma's Current Deferred Revenue was $98,000 in FY2021 (-99.1%), $11.52 million in FY2020 (-63.5%), $31.58 million in FY2019 (-27.2%) and $43.4 million in FY2018.
- Quarterly Current Deferred Revenue has run from a low of $24,000 in Q2 2022 to a high of $43.4 million in Q4 2018 over five years.
- The year-over-year decline in Current Deferred Revenue has ranged between 0.0% (Q3 2023) and 99.6% (Q2 2022) over the last five years.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $24,000 (Q2 2023), $24,000 (Q1 2023) and $24,000 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,175.59 Bn | 1,144.18 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 639.41 Bn | 557.93 Bn | 17.26 Bn |
| 3 | AbbVie | 502.56 Bn | 475.67 Bn | 12.70 Bn |
| 4 | Merck | 375.27 Bn | 329.65 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.16 Bn | 267.15 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.63 Bn | 242.32 Bn | 12.86 Bn |
| 7 | Amgen | 242.12 Bn | 197.52 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.40 Bn | 167.60 Bn | 6.22 Bn |
| 9 | Pfizer | 172.79 Bn | 119.44 Bn | 10.94 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Mar 31, 2023 | 24,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 98,000.00 |
| Sep 30, 2021 | 2.90 Mn |
| Jun 30, 2021 | 5.69 Mn |
| Mar 31, 2021 | 7.66 Mn |
| Dec 31, 2020 | 11.52 Mn |
| Sep 30, 2020 | 18.20 Mn |
| Jun 30, 2020 | 25.06 Mn |
| Mar 31, 2020 | 23.19 Mn |
| Dec 31, 2019 | 31.58 Mn |
| Sep 30, 2019 | 33.75 Mn |
| Jun 30, 2019 | 43.31 Mn |
| Mar 31, 2019 | 42.52 Mn |
| Dec 31, 2018 | 43.40 Mn |
API Access
Theravance Biopharma Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();